GB936806A - Steroid compounds - Google Patents
Steroid compoundsInfo
- Publication number
- GB936806A GB936806A GB173260A GB173260A GB936806A GB 936806 A GB936806 A GB 936806A GB 173260 A GB173260 A GB 173260A GB 173260 A GB173260 A GB 173260A GB 936806 A GB936806 A GB 936806A
- Authority
- GB
- United Kingdom
- Prior art keywords
- keto
- acetoxy
- methyl
- pregnene
- cadmium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises 17a -bromo-9(11)-pregnene compounds of the general formulae <FORM:0936806/IV(a)/1> <FORM:0936806/IV(a)/2> wherein R represents a hydrogen atom or an acyl group, R1 represents a hydrogen or bromine atom, R11 represents a C1-5 alkyl group, and R0 represents a keto or b -hydroxy group; the preparation thereof by contacting the corresponding steroids of the general formulae <FORM:0936806/IV(a)/3> <FORM:0936806/IV(a)/4> wherein R, R11 and R0 have the above significance, with bromine; this process may be extended by dehydrobrominating the resulting bromo substituted steroids to form steroids of the general formulae <FORM:0936806/IV(a)/5> <FORM:0936806/IV(a)/6> wherein R, R11 and R0 have the above significance. The above processes may be modified in that the steroids of the first two formulae above wherein R1 represents hydrogen and R, R11 and R0 have the above significance are prepared by brominating the corresponding 17(20)-unsaturated 20-enol derivatives of the steroids of the second two formulae above, for example, the 20-enol acylates thereof or the 20-zinc, cadmium or magnesium enolates thereof. In the case of the 17a -monobromo-compounds the dehydrobrominating step may be carried out with a tertiary amine such as pyridine, dimethylformamide or lithium chloride in an N,N-dilower-alkylamide. In the case of the 17a ,21-dibromo-compounds, the dehydrobrominating step may be carried out with an alkali metal iodide. 3a -Acetoxy- 11b -hydroxy- 16a -methyl-pregnane is prepared by treating 3a -acetoxy-11,20-diketo-D 16-pregnene with a reagent obtained by reacting cadmium chloride with methyl magnesium bromide in the presence of cuprous chloride and treating the reaction product with hydrochloric acid to form 3a -acetoxy- 11,20-diketo- 16a -methylpregnane, forming the corresponding 20-semicarbazone, reducing the semicarbazone with sodium borohydride to form 3a ,11b -dihydroxy-16a -methyl-20-ketone-pregnane, and acylating this compound. 3a -Acetoxy-16a -methyl- 20-keto-9(11)-pregnene is prepared by brominating 3a ,11b -dihydroxy-20-keto-pregnane or the corresponding 3-acetate in the presence of a strong acid catalyst to form 17a ,21-dibromo-3a -hydroxy-20-keto-9(11)-pregnene or the corresponding 3-acetate, treating this compound with sodium iodide to form 17a -bromo-3a -hydroxy-20-keto-9(11)-pregnene or the corresponding 3-acetate, dehydrobrominating this compound with pyridine to form 3a -hydroxy-20-keto-9(11), 16-pregnadiene or the corresponding 3-acetate, treating the 3a -acetoxy-20-keto-9(11), 16-pregnadiene with a reagent obtained by reacting cadmium chloride and methyl magnesium iodide in the presence of cuprous chloride and decomposing the reaction product. 3a ,20-Diacetoxy-11-keto- 16a -methyl-17(20)-pregnene is prepared by reacting 3a -acetoxy-11,20-diketo-16-pregnene with dimethyl cadmium to form the 20-cadmium enol derivative of 3a -acetoxy-11-keto-16a -methyl-17(20)-pregnene and refluxing this compound with acetic anhydride. 3a ,20- Diacetoxy- 16a -methyl- 9(11),17(20)-pregnadiene is prepared by reacting 3a -acetoxy- 16a -methyl -20-keto-9(11)- pregnene with acetic anhydride in the presence of 2,4-dinitrobenzenesulphonic acid. 20-Cadmium enol derivative of 3a -acetoxy-16a -methyl-9(11),17(20)-pregnadiene is prepared by reacting 3a -acetoxy-20-keto-9(11),16-pregnadiene with the product obtained by reacting cadmium chloride and methyl magnesium iodide in the presence of cuprous chloride.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US790041A US3083215A (en) | 1959-01-30 | 1959-01-30 | Process for preparing 16-alkyl-delta9,11-pregnenes |
US790042A US3013034A (en) | 1959-01-30 | 1959-01-30 | Process for the preparation of 16-alkyl-11-oxygenated-16-pregnenes |
Publications (1)
Publication Number | Publication Date |
---|---|
GB936806A true GB936806A (en) | 1963-09-11 |
Family
ID=27120989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB173260A Expired GB936806A (en) | 1959-01-30 | 1960-01-18 | Steroid compounds |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE587066A (en) |
CH (1) | CH387030A (en) |
ES (1) | ES255618A1 (en) |
GB (1) | GB936806A (en) |
-
1960
- 1960-01-18 GB GB173260A patent/GB936806A/en not_active Expired
- 1960-01-28 BE BE587066A patent/BE587066A/en unknown
- 1960-01-30 CH CH102860A patent/CH387030A/en unknown
- 1960-01-30 ES ES0255618A patent/ES255618A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE587066A (en) | 1960-07-28 |
CH387030A (en) | 1965-01-31 |
ES255618A1 (en) | 1960-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB956251A (en) | A process for introducing a í¸ dienic system into a 3-keto í¸ 19-nor steroid and novel 19-nor-4,9(10) - steroids and process of making them | |
US2813883A (en) | 9alpha-halo-17beta-hydroxy-17alpha-methyl-androstane-3, 11-diones | |
GB936806A (en) | Steroid compounds | |
GB929429A (en) | Preparation of steroid compounds | |
GB948268A (en) | Improvements in or relating to 11, 18-epoxy steroid compounds | |
US2946812A (en) | Synthesis of steroids | |
US2991295A (en) | 11beta-hydroxy-17alpha-alkyl estrogens and intermediates in the production thereof | |
GB995357A (en) | Synthesis of a-nor-steroids | |
US2881191A (en) | 17beta-hydroxy-17alpha-methylandrostane-3, 11-dione | |
GB935116A (en) | New cyclopentanophenanthrene derivatives and processes for the production thereof | |
US2831872A (en) | Synthesis of steroids | |
GB978540A (en) | Improvements in or relating to the production of 16ª-alkylthio-17-oxo-steroids | |
GB936391A (en) | Process for the fluorination of steroids | |
GB826364A (en) | Cyclopentanopolyhydrophenanthrene compounds | |
GB1055245A (en) | Improvements in or relating to 19-halo-10-a-androstane compounds | |
GB996079A (en) | 17ª‡,21-substituted methylenedioxy steroids and methods therefor | |
GB890989A (en) | New cyclopentanophenanthrene derivatives and processes for the production thereof | |
GB978725A (en) | Novel steroid compounds and processes for their perparation | |
GB865673A (en) | Improvements in or relating to steroids and the manufacture thereof | |
GB928411A (en) | 17ª -substituted steroids and process for their manufacture | |
GB965292A (en) | Halogenated steroid derivatives | |
GB674299A (en) | Manufacture of compounds of the androstane series | |
GB854672A (en) | Preparation of 12ª‡-halo-16ª‡,17ª‡,21-trihydroxy-4-pregnene-3,11,20-triones and 16ª‡,21-acyl esters thereof | |
GB883310A (en) | Improvements in or relating to hormonal agents | |
GB1057337A (en) | Novel 3-substituted-androst-11-ones and processes for their preparation |